IL6R and breast carcinoma: Metastasizing, but not non-metastasizing, cancer cells activated MDSCs, increasing their expression and secretion of both IL-6 and soluble IL-6Rα, and facilitated breast cancer cell invasiveness and distant metastasis through IL-6 trans-signaling, acting both in afferent and efferent metastatic pathways.